Cite

HARVARD Citation

    van der Meulen, M. et al. (n.d.). NCOG-05. IMPACT OF ADDITIONAL RITUXIMAB TO STANDARD THERAPY ON COGNITIVE PERFORMANCES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS. Neuro-oncology. p. vi159. [Online]. 
  
Back to record